Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting Drug Response: Overview
Pharmacogenomics: Identification of New Drug Targets
Venous Thrombosis IV: Nursing Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 3, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Vitor José Poletto Ferreira1, Alessandra Fatima da Costa1, Renan Pedra Souza2,3
1Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Prophylaxis for hereditary factor X deficiency (FXD) shows promise in reducing bleeds compared to on-demand treatment. However, further high-quality research is essential to confirm these findings for people with FXD.
Area of Science:
Background:
Conclusions: